유전체학 맞춤형 헬스 시장 보고서(2026년)

Genomics personalized health involves customizing medical care and treatments based on an individual's genomic data, taking into account their specific genetic characteristics, lifestyle choices, and environmental factors. This method utilizes progress in genomics, bioinformatics, and personalized medicine to offer more accurate and efficient healthcare solutions personalized to each person's genetic inclinations, susceptibilities, and responses to treatment.

The primary test types of genomics personalized health comprise oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others. Oncology testing involves employing genetic testing methods to identify cancer and ascertain its unique attributes, utilizing technologies such as NGS platforms, RT-PCR, microarray, and genetic analyzers. These tests cater to end users such as academic research institutes, diagnostic centers, and others.

Tariffs are impacting the genomics personalized health market by increasing costs of imported sequencing instruments, reagents, bioinformatics software, and high-performance computing infrastructure. Diagnostic and research institutions in North America and Europe are most affected due to reliance on globally sourced genomic technologies, while Asia-Pacific faces higher costs for expanding precision medicine programs. These tariffs are increasing testing costs and slowing infrastructure expansion. However, they are also encouraging domestic manufacturing of sequencing equipment, regional reagent production, and localized genomics data platforms, strengthening long-term ecosystem resilience.

The genomics personalized health market research report is one of a series of new reports from The Business Research Company that provides genomics personalized health market statistics, including genomics personalized health industry global market size, regional shares, competitors with a genomics personalized health market share, detailed genomics personalized health market segments, market trends and opportunities, and any further data you may need to thrive in the genomics personalized health industry. This genomics personalized health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomics personalized health market size has grown rapidly in recent years. It will grow from $18.5 billion in 2025 to $21.46 billion in 2026 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to advancements in sequencing technologies, declining costs of genomic testing, expansion of clinical genomics research, growth of personalized medicine initiatives, increasing availability of bioinformatics tools.

The genomics personalized health market size is expected to see rapid growth in the next few years. It will grow to $36.55 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing adoption of population-scale genomics programs, rising investments in AI-driven diagnostics, expansion of personalized therapeutics, growing integration of genomics in routine clinical care, increasing focus on predictive healthcare models. Major trends in the forecast period include increasing adoption of genomic data analytics platforms, rising use of AI for variant interpretation, expansion of personalized treatment pathways, growing integration of genomics in preventive healthcare, enhanced focus on precision diagnostics.

The increasing demand for personalized medicine is anticipated to drive the growth of the genomics personalized health market in the coming years. Personalized medicine, also referred to as precision medicine, is a healthcare approach that customizes medical treatment and practices according to the unique characteristics of each patient. This rising demand is fueled by a shift toward preventive healthcare, enhanced treatment outcomes, patient engagement and empowerment, economic advantages, and the growing prevalence of chronic and complex diseases. Genomics personalized health plays a key role in advancing personalized medicine by using individual genetic information to guide medical care, including prevention, diagnosis, treatment, and monitoring. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six approvals in 2022. Consequently, the increasing interest in personalized medicine is driving the growth of the genomics personalized health market.

Major companies in the genomics personalized health market are concentrating on developing innovative solutions, such as cloud-based software for tertiary analysis of clinical next-generation sequencing (NGS) data, to strengthen their market position. Clinical NGS data refers to genetic information obtained through sequencing technologies that enable high-throughput and detailed analysis of DNA or RNA samples in a clinical setting. For instance, in March 2023, Illumina, a US-based biotechnology firm specializing in DNA sequencing and array technologies, launched Connected Insights, a cloud-based platform for tertiary analysis of clinical NGS data. This platform is designed to streamline interpretation and reporting, particularly in oncology, and supports comprehensive genomic profiling. By integrating multiple third-party knowledge bases, Connected Insights enhances precision in data analysis and improves the efficiency of precision care initiatives.

In January 2023, Agilent Technologies Inc., a US-based life sciences and analytical instrumentation company, acquired Avida Biomed Inc. for US$30 million. This acquisition aims to strengthen Agilent's next-generation sequencing (NGS) capabilities and expand its presence in the rapidly growing clinical research and diagnostics markets. Avida Biomed Inc., a US-based biotechnology company, specializes in genomics and personalized health.

Major companies operating in the genomics personalized health market are Illumina Inc., Quest Diagnostics, Exact Sciences Corporation, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., Pacific Biosciences of California Inc., Personalis Inc., Invitae Corporation, GRAIL Inc., XCode Life Sciences Private Limited, BGI Genomics Co. Ltd., Genetic Technologies Limited, Eastern Biotech and Life Sciences, Tempus AI, Guardant Health, Freenome, Color Genomics, Helix, NantOmics, Novogenia GmbH, Clear Labs

North America was the largest region in the personalized health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomics personalized health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomics personalized health market consists of revenues earned by entities by providing services such as genomic sequencing, bioinformatics analysis, genetic testing, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomics personalized health market also includes sales of DNA sequencing kits, genomic data management solutions, pharmacogenomics tests, personalized wellness and nutrition products, and companion diagnostics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics Personalized Health Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses genomics personalized health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics personalized health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genomics personalized health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Test Type: Oncology Testing; Infectious Disease Testing; Orphan Disease Testing; Autoimmune Disease Testing; Obstetrics Testing
• 2) By Technology: NGS Platforms; Microarray; Genetic Analyzers
• 3) By End User: Academic Research Institutes; Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Oncology Testing: Cancer Genomic Profiling; Liquid Biopsy Testing; Tumor Mutational Burden Testing; Genetic Biomarker Testing
• 2) By Infectious Disease Testing: Next-Generation Sequencing (NGS) Tests; Microbial Genomic Profiling
• 3) By Orphan Disease Testing: Genetic Screening For Rare Diseases; Genetic Testing For Inherited Disorders; Targeted Gene Panels
• 4) By Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions; Immune System Gene Profiling; HLA Typing Tests
• 5) By Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT); Genetic Screening For Birth Defects; Carrier Screening Tests
• Companies Mentioned: Illumina Inc.; Quest Diagnostics; Exact Sciences Corporation; Natera Inc.; Adaptive Biotechnologies Corporation; Myriad Genetics Inc.; Pacific Biosciences of California Inc.; Personalis Inc.; Invitae Corporation; GRAIL Inc.; XCode Life Sciences Private Limited; BGI Genomics Co. Ltd.; Genetic Technologies Limited; Eastern Biotech and Life Sciences; Tempus AI; Guardant Health; Freenome; Color Genomics; Helix; NantOmics; Novogenia GmbH; Clear Labs
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Genomics Personalized Health Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Genomics Personalized Health Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Genomics Personalized Health Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Genomics Personalized Health Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Genomic Data Analytics Platforms
  • 4.2.2 Rising Use Of AI For Variant Interpretation
  • 4.2.3 Expansion Of Personalized Treatment Pathways
  • 4.2.4 Growing Integration Of Genomics In Preventive Healthcare
  • 4.2.5 Enhanced Focus On Precision Diagnostics

5. Genomics Personalized Health Market Analysis Of End Use Industries

• 5.1 Diagnostic Centers
• 5.2 Hospitals And Clinics
• 5.3 Academic Research Institutes
• 5.4 Biotechnology Companies
• 5.5 Precision Medicine Providers

6. Genomics Personalized Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Genomics Personalized Health Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Genomics Personalized Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Genomics Personalized Health Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Genomics Personalized Health Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Genomics Personalized Health Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Genomics Personalized Health Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Genomics Personalized Health Market Segmentation

• 9.1. Global Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing
• 9.2. Global Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• NGS Platforms, Microarray, Genetic Analyzers
• 9.3. Global Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Academic Research Institutes, Diagnostic Centers, Other End Users
• 9.4. Global Genomics Personalized Health Market, Sub-Segmentation Of Oncology Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cancer Genomic Profiling, Liquid Biopsy Testing, Tumor Mutational Burden Testing, Genetic Biomarker Testing
• 9.5. Global Genomics Personalized Health Market, Sub-Segmentation Of Infectious Disease Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Next-Generation Sequencing (NGS) Tests, Microbial Genomic Profiling
• 9.6. Global Genomics Personalized Health Market, Sub-Segmentation Of Orphan Disease Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Genetic Screening For Rare Diseases, Genetic Testing For Inherited Disorders, Targeted Gene Panels
• 9.7. Global Genomics Personalized Health Market, Sub-Segmentation Of Autoimmune Disease Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Genetic Screening For Autoimmune Conditions, Immune System Gene Profiling, HLA Typing Tests
• 9.8. Global Genomics Personalized Health Market, Sub-Segmentation Of Obstetrics Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Non-Invasive Prenatal Testing (NIPT), Genetic Screening For Birth Defects, Carrier Screening Tests

10. Genomics Personalized Health Market, Industry Metrics By Country

• 10.1. Global Genomics Personalized Health Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
• 10.2. Global Genomics Personalized Health Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Genomics Personalized Health Market Regional And Country Analysis

• 11.1. Global Genomics Personalized Health Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 11.2. Global Genomics Personalized Health Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Genomics Personalized Health Market

• 12.1. Asia-Pacific Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. Asia-Pacific Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Genomics Personalized Health Market

• 13.1. China Genomics Personalized Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 13.2. China Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Genomics Personalized Health Market

• 14.1. India Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Genomics Personalized Health Market

• 15.1. Japan Genomics Personalized Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 15.2. Japan Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Genomics Personalized Health Market

• 16.1. Australia Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Genomics Personalized Health Market

• 17.1. Indonesia Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Genomics Personalized Health Market

• 18.1. South Korea Genomics Personalized Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. South Korea Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Genomics Personalized Health Market

• 19.1. Taiwan Genomics Personalized Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. Taiwan Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Genomics Personalized Health Market

• 20.1. South East Asia Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. South East Asia Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Genomics Personalized Health Market

• 21.1. Western Europe Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Western Europe Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Genomics Personalized Health Market

• 22.1. UK Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Genomics Personalized Health Market

• 23.1. Germany Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Genomics Personalized Health Market

• 24.1. France Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Genomics Personalized Health Market

• 25.1. Italy Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Genomics Personalized Health Market

• 26.1. Spain Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Genomics Personalized Health Market

• 27.1. Eastern Europe Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Eastern Europe Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Genomics Personalized Health Market

• 28.1. Russia Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Genomics Personalized Health Market

• 29.1. North America Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. North America Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Genomics Personalized Health Market

• 30.1. USA Genomics Personalized Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. USA Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Genomics Personalized Health Market

• 31.1. Canada Genomics Personalized Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. Canada Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Genomics Personalized Health Market

• 32.1. South America Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 32.2. South America Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Genomics Personalized Health Market

• 33.1. Brazil Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Genomics Personalized Health Market

• 34.1. Middle East Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Middle East Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Genomics Personalized Health Market

• 35.1. Africa Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 35.2. Africa Genomics Personalized Health Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Genomics Personalized Health Market Regulatory and Investment Landscape

37. Genomics Personalized Health Market Competitive Landscape And Company Profiles

• 37.1. Genomics Personalized Health Market Competitive Landscape And Market Share 2024
  • 37.1.1. Top 10 Companies (Ranked by revenue/share)
• 37.2. Genomics Personalized Health Market - Company Scoring Matrix
  • 37.2.1. Market Revenues
  • 37.2.2. Product Innovation Score
  • 37.2.3. Brand Recognition
• 37.3. Genomics Personalized Health Market Company Profiles
  • 37.3.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.2. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.3. Exact Sciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.4. Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.5. Adaptive Biotechnologies Corporation Overview, Products and Services, Strategy and Financial Analysis

38. Genomics Personalized Health Market Other Major And Innovative Companies

• Myriad Genetics Inc., Pacific Biosciences of California Inc., Personalis Inc., Invitae Corporation, GRAIL Inc., XCode Life Sciences Private Limited, BGI Genomics Co. Ltd., Genetic Technologies Limited, Eastern Biotech and Life Sciences, Tempus AI, Guardant Health, Freenome, Color Genomics, Helix, NantOmics

39. Global Genomics Personalized Health Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Genomics Personalized Health Market

41. Genomics Personalized Health Market High Potential Countries, Segments and Strategies

• 41.1. Genomics Personalized Health Market In 2030 - Countries Offering Most New Opportunities
• 41.2. Genomics Personalized Health Market In 2030 - Segments Offering Most New Opportunities
• 41.3. Genomics Personalized Health Market In 2030 - Growth Strategies
  • 41.3.1. Market Trend Based Strategies
  • 41.3.2. Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer